Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

FDA

FDA says no to BioMarin’s Duchenne Muscular Dystrophy drug

January 14, 2016 Medical Communications, Sales and Marketing BioMarin, Duchenne Muscular Dystrophy, FDA, Kyndrisa, drisapersen

The FDA has rejected BioMarin’s Duchenne Muscular Dystrophy (DMD) drug Kyndrisa, saying there was not enough evidence that the drug …
News
Hospira logo

Pfizer may sell off Hospira unit for $2 billion

January 14, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps

Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …
News
Ninlaro

Takeda in myeloma research drive

January 14, 2016 Medical Communications, Research and Development Ninlaro, Phase II, Takeda, Takeda oncology, eric low, ixazomib, multiple myeloma, myeloma

Takeda is funding the research charity Myeloma UK to run a Phase II study of its multiple myeloma treatment Ninlaro, …
News

Cell and Gene Therapy World: PCI Pharma Services expert to present on cold chain challenges

January 13, 2016 Medical Communications

Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at Cell and Gene Therapy World (January …
News
Press release
dr_robert_califf_image_via_duke_university_school_of_medicine

Senate panel approves Dr Robert Califf as FDA commissioner

January 13, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Robert Califf, FDA, FDA commissioner, Senate

A senate panel has approved president Obama’s nominee Dr Robert Califf to lead the FDA by a clear majority, although …
Appointment
az_palmer

Three appointments in AstraZeneca’s global media relations team

January 11, 2016 Medical Communications AstraZeneca

Neil Burrows has joined as head of global media relations, following Esra Erkal-Paler’s promotion to head of global external communications.Burrows …
Appointment
GSK logo

GSK explains decision to halt payments to doctors

January 8, 2016 Medical Communications, Sales and Marketing GSK, doctor payments, medical education, transparency

GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …
News
Neil Woodford

Investment group renews calls for GSK to split

January 8, 2016 Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure

Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …
News
Valeant logo

Why 2016 could be a make or break year for Valeant

January 8, 2016 Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …
Feature
FDA sign

FDA review for Sanofi and Regeneron’s biologic arthritis drug

January 8, 2016 Medical Communications, Sales and Marketing FDA, Regeneron, Sanofi, biologics, rheumatoid arthritis, sarilumab

The FDA has accepted for review a Biologics License Application (BLA) from Sanofi and Regeneron for the rheumatoid arthritis treatment …
News
Roche building

Roche presents new data for advanced bladder cancer immunotherapy

January 8, 2016 Medical Communications, Research and Development Roche, atezolizumab, bladder cancer

Roche has announced updated results from a pivotal Phase II study, showing its investigational cancer immunotherapy atezolizumab extended median progression …
News
Novartis image

Novartis and Qualcomm to develop smart inhaler technology for COPD

January 8, 2016 Manufacturing and Production, Medical Communications COPD, Novartis, Qualcomm Life, breezhaler, digital inhaler, qualcomm

Novartis has enlisted Qualcomm life to help the pharma giant develop the ‘next generation’ of its Breezhaler device for patients …
News
victoria_photo_feb_14

New head for AI drug discovery firm Molplex

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Molplex, Victoria Camargo

The artificial intelligence drug discovery company Molplex has appointed Victoria Camargo as its new chief executive. Camargo replaces the co-founder …
Appointment
HIV infected cell

ViiV and Janssen to test new HIV regimen in Phase III trial

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development Edurant, HIV, Janssen, ViiV Healthcare, cabotegravir, collaboration, phase III, rilpivirine

Janssen has formalised its collaboration with ViiV Healthcare on the Phase III development and commercialisation of a two-drug regimen to …
News
dr_paolo_paoletti

PsiOxus Therapeutics appoints Dr Paolo Paoletti as chairman of the board

January 7, 2016 Manufacturing and Production, Medical Communications, Research and Development Cancer, Dr Paolo Paoletti, GSK, PsiOxus Therapeutics, immuno-oncology, oncology

Immuno-oncology company PsiOxus Therapeutics has appointed Kesios Therapeutics chief executive, and former president of GSK Oncology, Dr Paolo Paoletti, as chairman …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025